Trista Morrison
Human Resources Officer at VOYAGER THERAPEUTICS, INC.
Profile
Trista Morrison is currently the Director at Network of Tyrosinemia Advocates, Inc. and the Chief of Staff & SVP Corporate Affairs at Voyager Therapeutics, Inc. She previously worked as the Director-Corporate Communications at Ironwood Pharmaceuticals, Inc., the Head-Media Relations at Gemin X Pharmaceuticals US, Inc., and the Chief Communications Officer at Saniona AB.
Ms. Morrison completed her undergraduate degree at Tulane University (Louisiana).
Trista Morrison active positions
Companies | Position | Start |
---|---|---|
VOYAGER THERAPEUTICS, INC. | Human Resources Officer | - |
Network of Tyrosinemia Advocates, Inc. | Director/Board Member | - |
Former positions of Trista Morrison
Companies | Position | End |
---|---|---|
IRONWOOD PHARMACEUTICALS, INC. | Public Communications Contact | - |
SANA AB | Public Communications Contact | - |
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Public Communications Contact | - |
Training of Trista Morrison
Tulane University (Louisiana) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
SANA AB | Health Technology |
VOYAGER THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
Network of Tyrosinemia Advocates, Inc. |
- Stock Market
- Insiders
- Trista Morrison